Vanizem™ Aframomum
melegueta Targets Endocannabinoid System
to Provide Clinically Demonstrated Benefits in as Little as 3
Days
MORRISTOWN, N.J., July 25,
2024 /PRNewswire/ -- PLT Health Solutions
announced today that it is adding to its industry-leading cognitive
health portfolio in North America
with a novel botanical ingredient that has been clinically
demonstrated to reduce stress, enhance mood and happiness and
improve sleep and waking outcomes. Called Vanizem™, the ingredient
is a proprietary selection and extraction of the West African
flowering plant Aframomum melegueta (Grains of
Paradise) with standardized bioactives. In a recently completed
clinical study, Vanizem was shown to provide improvements in
self-reported tension scores (POMS) and significant improvements in
sleep quality score (LSEQ) along with improvements in mood, vigor,
ease of falling asleep and easier morning awakening. The ingredient
was introduced to European markets by PLT innovation partner
Nektium Pharma (Las Palmas, Spain)
in March of this year. PLT Health Solutions is the exclusive sales
and marketing partner for Vanizem in North America.
According to Devin Stagg, Chief
Operating Officer for PLT Health Solutions, Vanizem represents a
unique approach and opportunity for consumer products companies in
the fast growing cognitive health market. "There is no doubt that
cognitive health – particularly when it comes to stress, mood and
sleep – has captured consumers' attention at every age demographic.
At PLT, we are focused on supporting this opportunity with a range
of ingredients that offer novel benefits backed by solid clinical
science," he said. "Vanizem is exciting because it is fast-acting
and experiential. Subjects taking Vanizem in the clinical trial saw
statistically significant improvements at three days – with a low
dose," he said.
Compelling Product Features
Beyond the benefits and
clinical science, Vanizem offers some features that should be of
interest to product formulators and consumers. The clinical work
for Vanizem was done with a very low 100-150 mg/day dose which
means better compliance and easier product formulation.
Improvements were seen starting in only three days, making it an
experiential ingredient. Vanizem features a proprietary
microencapsulation technology that enhances product stability over
time. Like all Nektium ingredients, the starting point materials
for Vanizem are sustainably grown and harvested. The extraction
process is 'gentle,' and every gram of the material is subject to
Nektium's ID Assessment Program that assures HPLC-measured
consistency of active ingredients.
According to Jennifer Murphy, MS,
RD, Director of Innovation & Clinical Development for PLT
Health Solutions, Vanizem can help companies develop a diverse
range of exciting consumer products. "The clinical data on Vanizem
shows that it can enhance formulations targeting stress and mood as
well as those designed to promote and improve sleep. The effects on
sleep are especially remarkable, given subjects took it early in
the day. This speaks to Vanizem's powerful impact on stress
and tension. This ingredient and these data offer a fantastic
opportunity for product development creativity," she said.
According to Nektium Commercial & Partnership Director
Bruno Berheide, the unique mechanism
of action of Vanizem offers an exciting alternative in the crowded
cognitive health ingredient space. "Vanizem is unique in this
space, not just because of the exciting benefits it offers, but
because of its mechanism of action – targeting the endocannabinoid
system. We think consumer product companies will want to take a
look at how this can help them create and message new products," he
said
For more information visit
www.plthealth.com/vanizem.
These messaging concepts are for consideration and
evaluation. Any claims used for products should reference the
appropriate FDA disclaimer: "This statement has not been evaluated
by the Food and Drug Administration. This product is not intended
to diagnose, treat, cure, or prevent any disease."
Media Contact:
Mark
Falconer
Sciencewerks, LLC
E-mail: 380889@email4pr.com
Company Contact:
Steve Fink, Vice President,
Marketing
PLT Health Solutions, Inc.
E-mail: 380889@email4pr.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/plt-launches-new-cognitive-health-ingredient-that-offers-reduced-stress-enhanced-mood-and-improved-sleep-into-north-american-market-302206623.html
SOURCE PLT Health Solutions